tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Technical Analysis

Compare
362 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Neutral
5Bullish
1Neutral
4Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is -1.13, suggesting TransCode Therapeutics is a Sell.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 1.44, while TransCode Therapeutics’s (RNAZ) share price is $0.5, making it a Sell.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 3.64, while TransCode Therapeutics’s (RNAZ) share price is $0.5, making it a Sell.

TransCode Therapeutics (RNAZ) Pivot Points

Apr 02, 2025, 10:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.28
0.36
0.43
0.50
0.57
0.64
0.71
Fibonacci
0.36
0.41
0.44
0.50
0.55
0.59
0.64
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Apr 02, 2025, 10:23 AM
Period
Simple
Exponential
MA5
0.53Buy
0.56Sell
MA10
0.67Sell
0.71Sell
MA20
0.92Sell
1.44Sell
MA50
4.75Sell
3.64Sell
MA100
6.33Sell
6.74Sell
MA200
12.14Sell
13.11Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 0.71, while TransCode Therapeutics’s (RNAZ) share price is $0.5, making it a Sell.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 6.74, while TransCode Therapeutics’s (RNAZ) share price is $0.5, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $0.5 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 4.75, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $0.5 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 6.33, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $0.5 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 12.14, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Apr 02, 2025, 10:23 AM
Name
Value
Implied Action
RSI (14)
28.58
Buy
STOCH (9,6)
5.04
Buy
STOCHRSI (14)
5.04
Buy
MACD (12,26)
-1.13
Sell
ADX (14)
17.33
Buy
Williams %R
-90.84
Buy
CCI (14)
-77.99
Neutral
ATR (14)
0.53
-
Ultimate Oscillator
23.58
Sell
ROC
-47.06
Sell
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 28.58, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 17.33, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is -77.99, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is -47.06, creating a Sell signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Sell.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 28.58, which suggests RNAZ is a Buy.
      What is RNAZ’s MACD?
      RNAZ’s MACD is -1.13, which suggests RNAZ is a Sell.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 0.53, which suggests RNAZ is a Buy.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 0.92, which suggests RNAZ is a Sell.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 4.75, which suggests RNAZ is a Sell.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 12.14, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -90.84, which suggests RNAZ is a Buy.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is -77.99, which suggests RNAZ is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis